Fengxia Chen
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
Papers in
-
- RNA modifications and cancer 4
- RNA Research and Splicing 3
- Oncology 12
- Cancer-related Molecular Pathways 3
- Co-authors
- Feifei Pu (18 shared papers)Zengwu Shao (14 shared papers)Qingqing Wang (8 shared papers)Yunfeng Zhou (6 shared papers)Honghui Guo (1 shared paper)Wenhua Ling (1 shared paper)Di Li (1 shared paper)Qian He (3 shared papers)
In The Last Decade
Fengxia Chen
64 papers receiving 931 citations
Peers
Comparison fields: 5 of 119
- Cancer Research 130
- Biochemistry 45
- Oncology 143
- Biomaterials 75
- Molecular Biology 295
Countries citing papers authored by Fengxia Chen
This map shows the geographic impact of Fengxia Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengxia Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengxia Chen more than expected).
Fields of papers citing papers by Fengxia Chen
This network shows the impact of papers produced by Fengxia Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengxia Chen. The network helps show where Fengxia Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengxia Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 94 | |
| 2 | 2017 | 62 | |
| 3 | 2016 | 48 | |
| 4 | 2022 | 48 | |
| 5 | 2015 | 42 | |
| 6 | 2017 | 32 | |
| 7 | 2024 | 29 | |
| 8 | 2021 | 28 | |
| 9 | 2021 | 27 | |
| 10 | 2023 | 27 | |
| 11 | 2019 | 26 | |
| 12 | 2021 | 25 | |
| 13 | 2019 | 24 | |
| 14 | 2021 | 22 | |
| 15 | 2019 | 21 | |
| 16 | 2020 | 20 | |
| 17 | 2019 | 18 | |
| 18 | 2016 | 17 | |
| 19 | 2020 | 17 | |
| 20 | 2023 | 14 |
About Fengxia Chen
Fengxia Chen is a scholar working on Molecular Biology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Cancer Research, having authored 71 papers that have together received 940 indexed citations. Recurring topics across this work include Thermal Regulation in Medicine (5 papers), Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (4 papers), RNA Research and Splicing (3 papers), BRCA gene mutations in cancer (3 papers), Thermoregulation and physiological responses (3 papers), Cancer-related Molecular Pathways (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (130 citations), Biochemistry (45 citations), Oncology (143 citations), Biomaterials (75 citations) and Molecular Biology (295 citations). Fengxia Chen has collaborated with scholars based in China and Taiwan. Frequent co-authors include Feifei Pu, Zengwu Shao, Qingqing Wang, Yunfeng Zhou, Honghui Guo, Wenhua Ling, Di Li, Qian He, Rui Song and Z. Zhang. Their work appears in journals such as OncoTargets and Therapy, Frontiers in Oncology, Environmental Science Water Research & Technology, International Journal of Oncology and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.